biosimilars

Businesspeople reaching agreement
Pharma

Partners Alvotech, Teva eye 2026 Eylea biosimilar launch

The Eylea biosim has been under FDA review for much of this year. Back in February, the companies said they expected a decision by the end of 2025.
Eric Sagonowsky Dec 19, 2025 10:40am
FDA

FDA finalizes guidance on biosimilar promotional materials

Dec 10, 2025 12:45pm
pay deal hand over cash licensing transaction money

Biocon buys out Viatris and others from biosimilar subsidiary

Dec 9, 2025 1:56pm
Mark Cuban

Mark Cuban says FDA should lower fees for generic drug approvals

Dec 5, 2025 4:15pm
FDA

FDA’s plan to boost biosims could stall at the patent office

Nov 17, 2025 9:04am
photo of a green light on a stoplight

Poherdy, first biosimilar to Roche's Perjeta, scores FDA nod

Nov 14, 2025 10:52am